Over-expression of the p110β but not p110α isoform of PI 3-kinase inhibits motility in breast cancer cells

Cell Motility and the Cytoskeleton

Volumn 59, Issue 3, 2004, Pages 180-188

  Yip, Shu Chin ^a   El Sibai, Mirvat ^a   Hill, Karen M ^a   Wu, Haiyan ^a   Fu, Zheng ^a   Condeelis, John S ^a   Backer, Jonathan M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Actin; Adenocarcinoma; Breast cancer; Motility; PI 3 kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P110; PROTEIN P110ALPHA; PROTEIN P110BETA; PROTEIN P85; RAS PROTEIN; UNCLASSIFIED DRUG; HYBRID PROTEIN; ISOENZYME;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CATALYSIS; CELL MIGRATION; CELL MOTILITY; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LAMELLIPODIUM; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ADENOCARCINOMA; ANIMAL; BREAST TUMOR; CELL MOTION; CELL SHAPE; CELL SURFACE; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; CELL SURFACE EXTENSIONS; FEMALE; HUMANS; ISOENZYMES; RATS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 7244221431     PISSN: 08861544     EISSN: None     Source Type: Journal    
DOI: 10.1002/cm.20032     Document Type: Article

References (27)

1. Beeton CA, Chance EM, Foukas LC, Shepherd PR. 2000. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases. Biochem J 350:353-359.
2. Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, Wetzker R, Wymann MP. 1998. Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. Science 282:293-296.
3. Czupalla C, Culo M, Muller EC, Brock C, Reusch HP, Spicher K, Krause E, Nurnberg B. 2003. Identification and characterization of the autophosphorylation sites of phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem 278:11536-11545.
4. Foukas LC, Beeton CA, Jensen J, Phillips WA, Shepherd PR. 2004. Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo. Mol Cell Biol 24:966-975.
5. Funamoto S, Meili R, Lee S, Parry L, Firtel RA. 2002. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 109:611-623.
6. Hill K, Welti S, Yu JH, Murray JT, Yip SC, Condeelis JS, Segall JE, Backer JM. 2000. Specific requirement for the p85-p110a phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells. J Biol Chem 275:3741-3744.
7. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, Wymann MP. 2000. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287:1049-1053.
8. Hooshmand-Rad R, Hájková L, Klint P, Karlsson R, Vanhaesebroeck B, Claesson-Welsh L, Heldin CH. 2000. The PI 3-kinase isoforms p110a and p110b have differential roles in PDGF- and insulin-mediated signaling. J Cell Sci 113:207-214.
9. Huang YE, Iijima M, Parent CA, Funamoto S, Firtel RA, Devreotes P. 2003. Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Mol Biol Cell 14:1913-1922.
10. Ichetovkin I, Grant W, Condeelis J. 2002. Cofilin produces newly polymerized actin filaments that are preferred for dendritic nucleation by the Arp2/3 complex. Curr Biol 12:79-84.
11. Jones GE, Prigmore E, Calvez R, Hogan C, Dunn GA, Hirsch E, Wymann MP, Ridley AJ. 2003. Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1. Exp Cell Res 290:120-131.
12. Kurosu H, Maehama T, Okada T, Yamamoto T, Hoshino S, Fukui Y, Ui M, Hazeki O, Katada T. 1997. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide. J Biol Chem 272:24252-24256.
13. McIlroy J, Chen DX, Wjasow C, Michaeli T, Backer JM. 1997. Specific activation of p85-p110 phosphatidylinositol 3′-kinase stimulates DNA synthesis by ras- and p70 S6 kinase- dependent pathways. Mol Cell Biol 17:248-255.
14. Rickert P, Weiner OD, Wang F, Bourne HR, Servant G. 2000. Leukocytes navigate by compass: roles of PI3Kgamma and its lipid products. Trends Cell Biol 10:466-473.
15. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527-532.
16. Rodriguez-Viciana P, Warne PH, Khwaja A, Maarte BM, Pappin D, Das P, Waterfield MD, Ridley AJ, Downward J. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467.
17. Sadhu C, Masinovsky B, Dick K, Sowell CG, Staunton DE. 2003. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 170:2647-2654.
18. Sawyer C, Sturge J, Bennett DC, O'Hare MJ, Allen WE, Bain J, Jones GE, Vanhaesebroeck B. 2003. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. Cancer Res 63:1667-1675.
19. Soll DR, Voss E, Varnum-Finney B, Wessels D. 1988. "Dynamic Morphology System": a method for quantitating changes in shape, pseudopod formation, and motion in normal and mutant amoebae of Dictyostelium discoideum. J Cell Biochem 37:177-192.
20. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR. 2002. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 22:965-977.
21. Vanhaesebroeck B, Higashi K, Raven C, Welham M, Anderson S, Brennan P, Ward SG, Waterfield MD. 1999. Autophosphorylation of p110d phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J 18:1292-1302.
22. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD. 2001. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602.
23. Vanhaesebroeck B, Jones GE, Allen WE, Zicha D, Hooshmand-Rad R, Sawyer C, Wells C, Waterfield MD, Ridley AJ. 1999b. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nature Cell Biol 1:69-71.
24. Weaver AM, Young ME, Lee WL, Cooper JA. 2003. Integration of signals to the Arp2/3 complex. Curr Opin Cell Biol 15:23-30.
25. Welch HC, Coadwell WJ, Stephens LR, Hawkins PT. 2003. Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett 546(1):93-97.
26. Wymann MP, Bjorklof K, Calvez R, Finan P, Thomast M, Trifilieff A, Barbier M, Altruda F, Hirsch E, Laffargue M. 2003. Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem Soc Trans 31:275-280.
27. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. 1998. Regulation of the p85/p110 phosphatidylinositol 3′-kinase: Stabilization and inhibition of the p110-alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18:1379-1387.